Evidence map›Paper›PMID 27918592›Full record

ArticlePloS one2016

MicroRNA-497 Induces Apoptosis and Suppresses Proliferation via the Bcl-2/Bax-Caspase9-Caspase3 Pathway and Cyclin D2 Protein in HUVECs.

Ridong Wu, Shi Tang, Mian Wang, Xiangdong Xu, Chen Yao, Shenming Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. miR-497 Target Gene Regulatory Network in Angiosarcoma.Molecular cancer research : MCR · 2024
    Article
  5. Article
  6. Article
  7. Target gene regulatory network of miR-497 in angiosarcoma.bioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. In Vitro Anticancer Activity of Methanolic Extract ofMolecules (Basel, Switzerland) · 2022
    Article
  10. Bioinformatics analysis of BIRC5 in human cancers.Annals of translational medicine · 2022
    Article
  11. Article
  12. Article
  13. Regulatory Non-coding RNAs in Atherosclerosis.Handbook of experimental pharmacology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases.Frontiers in cell and developmental biology · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ridong WuDepartment of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China.
Shi TangDepartment of Breast Surgery, Dongguan Maternal & Children Health Hospital, Dongguan, P. R. China.
Mian WangDepartment of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China.
Xiangdong XuDepartment of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China.
Chen YaoDepartment of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China.
Shenming WangDepartment of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China.
Sun Yat-sen University · CNDongguan People’s Hospital · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMicroRNAs play crucial roles in various types of diseases. However, to date, no information about the role of miR-497 in the development of atherosclerosis has been reported. This study investigated the possible role of miR-497 in vascular endothelial cell injury during the early stage of atherosclerosis. MATERIALS AND

methodsThe expression level of miR-497 in human umbilical vein endothelial cells (HUVECs) exposed to ox-LDL was detected using qRT-PCR. To perform gain of function and loss of function analyses, miR-497 mimics were transfected into HUVECs, and miR-497 inhibitors were transfected into HUVECs stimulated with ox-LDL. Flow cytometry was used to analyze cell cycle progression and apoptosis. EdU and CCK-8 assays were employed to detect DNA synthesis and cell proliferation, respectively. After bioinformatics prediction, a dual Luciferase Reporter assay was used to analyze the direct target genes of miR-497. The mRNA and protein levels of the target genes were detected using qRT-PCR and western blot analyses, respectively. Caspase-9/3 activity was analyzed to determine the mechanism of endothelial dysfunction.

resultsWe showed that miR-497 was significantly upregulated in HUVECs stimulated with ox-LDL. Ectopic expression of miR-497 suppressed cell proliferation, induced apoptosis and increased the activity of caspase-9/3. After verification, Bcl2 and CCND2 were shown to be direct target genes of miR-497 in HUVECs. MiR-497 significantly suppressed cell proliferation by arresting the cell cycle through the CCND2 protein and induced apoptosis through the Bcl2/Bax-caspase9-caspase3 pathway.

conclusionOverall, our study shows that miR-497 might play a role in the development of atherosclerosis by inducing apoptosis and suppressing the proliferation of vascular endothelial cells. Therefore, miR-497 could be a potential therapeutic target for the treatment of atherosclerosis.

Indexed as

ApoptosisAtherosclerosisbcl-2-Associated X ProteinCaspase 3Caspase 9Cell ProliferationCells, CulturedCyclin D2HumansHuman Umbilical Vein Endothelial CellsLipoproteins, LDLMicroRNAsProto-Oncogene Proteins c-bcl-2RNA, Messengerbcl-2-Associated X ProteinCaspase 3Caspase 9CCND2 protein, humanCyclin D2Lipoproteins, LDLMicroRNAsMIRN497 microRNA, humanoxidized low density lipoproteinProto-Oncogene Proteins c-bcl-2RNA, Messenger

Identifiers

PMID27918592
PMCPMC5137897
OpenAlexW2560625204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.